Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8-week double-blind placebo-controlled armodafinil study in bipolar I depression
2007-007555-14Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar I disorder and major depressive disorder (MDD) comparing Armodafinil with Placebo (2 arms). Primary endpoint: IDS-C30 total score. Started Apr 2008; status: completed.
02
Drugs
armodafinil
03
Conditions
bipolar I disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on 2007-007555-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007555-14.